Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. The study may pave the ...

A new study published in the journal PNAS by researchers at the Department of Clinical Neuroscience, Karolinska Institutet, ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

UAE doctors warn that summer heat can worsen health issues. People with neurological and cardiovascular diseases are at ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

For most people with MS, a cup or two a day is fine and may even help some symptoms like fatigue and cognitive function. But ...

Studies in recent years have shown an that there is an increased incidence of multiple sclerosis among Black women.

Multiple sclerosis (MS) affects an estimated 2.3 million ... MS is marked by chronic inflammation and demyelination in the central nervous system. Demyelination is the process in which the myelin ...

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory small molecule therapy that can cross the blood-brain barrier may be attractive ...